Literature DB >> 15142161

Modified ureterosigmoidostomy (Mainz II): a long-term follow-up.

T Nitkunan1, R Leaver, H R H Patel, C R J Woodhouse.   

Abstract

OBJECTIVE: To assess the long-term results in patients treated using a modified ureterosigmoidostomy (Mainz II). PATIENTS AND METHODS: Between 1994 and 1999, 17 patients had their lower urinary tract reconstructed by a ureterosigmoidostomy, modified by reconfiguring the rectum to make a low-pressure reservoir (Mainz II). All patients were followed on a standard protocol. Data were extracted from the database and from a review of the case-notes. In 12 patients the procedure was with a radical cystectomy for carcinoma. Five had a failed conventional ureterosigmoidostomy for bladder exstrophy and therefore proceeded to a Mainz II. The data on continence and complications were retrieved for a retrospective analysis; the mean (range) follow-up was 6.4 (4-8.6) years.
RESULTS: Ten of those with bladder cancer and one in the revision group were continent. Two patients in the revision group had sufficiently severe nocturnal incontinence to require conversion to a colonic conduit. Seven of the 17 patients had hyperchloraemic acidosis, one had pyelonephritis and one had renal stones. There were no anastomotic neoplasms.
CONCLUSION: The Mainz II has a good outcome if used as the primary procedure. In patients with an existing ureterosigmoidostomy who are incontinent, detubularization of the rectosigmoid alone is unlikely to restore continence.

Entities:  

Mesh:

Year:  2004        PMID: 15142161     DOI: 10.1111/j.1464-410X.2004.04778.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  2 in total

1.  [The history of ureterosigmoidostomy].

Authors:  S C Müller; P J Bastian
Journal:  Urologe A       Date:  2008-01       Impact factor: 0.639

2.  Investigation of anal sphincter function following Mainz pouch type II urinary diversion after radical cystectomy.

Authors:  M Szűcs; A Keszthelyi; A Szendrői; P Dombóvári; A Majoros; S Mavrogenis; P Riesz; L Keszthelyi; I Asztalos; I Romics
Journal:  Int Urol Nephrol       Date:  2012-02-25       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.